PROMES: A Clinical Study in Which Researchers Want to Learn More About the Safety Profile of MESIGYNA (Norethisterone Enantate 50 mg and Estradiol Valerate 5 mg) Used as a Medication to Prevent Pregnancy for Adult Women in Reproductive Age in the Peruvian Population at the Outpatient Clinic.

NCT03901131 · clinicaltrials.gov ↗

COMPLETED

Status

296

Enrollment

INDUSTRY

Sponsor class

Conditions

Contraceptive

Interventions

DRUG: Norethisterone enantate/estradiol valerate (Mesigyna, BAY98-7040)

Sponsor

Bayer